Tumor Size Is a Critical Factor in Adjuvant Chemotherapy for T3-4aN0M0 Gastric Cancer Patients after D2 Gastrectomy

MLA

Shi Chen, et al. “Tumor Size Is a Critical Factor in Adjuvant Chemotherapy for T3-4aN0M0 Gastric Cancer Patients after D2 Gastrectomy.” Gastroenterology Research and Practice, vol. 2017, Jan. 2017. EBSCOhost, https://doi.org/10.1155/2017/4928736.

APA

Shi Chen, Li-Ying Ou-Yang, Run-Cong Nie, Yuan-Fang Li, Jun Xiang, Zhi-Wei Zhou, Ying-Bo Chen, & Jun-Sheng Peng. (2017). Tumor Size Is a Critical Factor in Adjuvant Chemotherapy for T3-4aN0M0 Gastric Cancer Patients after D2 Gastrectomy. Gastroenterology Research and Practice, 2017. https://doi.org/10.1155/2017/4928736

Chicago

Shi Chen, Li-Ying Ou-Yang, Run-Cong Nie, Yuan-Fang Li, Jun Xiang, Zhi-Wei Zhou, Ying-Bo Chen, and Jun-Sheng Peng. 2017. “Tumor Size Is a Critical Factor in Adjuvant Chemotherapy for T3-4aN0M0 Gastric Cancer Patients after D2 Gastrectomy.” Gastroenterology Research and Practice 2017 (January). doi:10.1155/2017/4928736.